Takeda Pharmaceutical Company Overview

  • Status
  • Public

  • Employees
  • 47,347

Employees
  • Stock Symbol
  • 4502

Stock Symbol
  • Investments
  • 57

  • Share Price
  • $27.87

  • (As of Monday Closing)

Takeda Pharmaceutical Company General Information

Description

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Contact Information

Website
www.takeda.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
  • 1-1, Nihonbashi-Honcho 2-Chome
  • Chuo-Ku
  • Tokyo, 103-8668
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Pharmaceutical Company Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$27.87 $28.15 $26.10 - $34.88 $43.3B 1.55B 5.53M $1.08

Takeda Pharmaceutical Company Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 71,840,075 76,014,887 96,707,668 90,260,680
Revenue 30,605,957 31,768,761 30,156,800 30,268,671
EBITDA 7,845,376 8,933,006 9,948,472 6,076,408
Net Income 1,681,933 2,047,822 3,545,896 406,879
Total Assets 102,974,770 107,974,090 117,048,645 118,633,583
Total Debt 33,693,686 35,604,125 42,019,175 47,128,342
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Takeda Pharmaceutical Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request a free trial

Takeda Pharmaceutical Company Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The co
Pharmaceuticals
Tokyo, Japan
47,347 As of 2022
00000000

000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000 000000000
Tokyo, Japan
00000 As of 0000
00.000
00000000 00.000

000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Takeda Pharmaceutical Company Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Otsuka Holdings Corporation Tokyo, Japan 00000 00.000 00000000 00.000
00000000 Corporation Basel, Switzerland 000000 000000000000
000000000000000 Corporation Brentford, United Kingdom 00000 000000000
00000000 00000 Corporation Mumbai, India 00 00.000 00000000000 00.000
00000000 000000 Corporation Tokyo, Japan 00000 000000&0
You’re viewing 5 of 14 competitors. Get the full list »

Takeda Pharmaceutical Company Patents

Takeda Pharmaceutical Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220106357-A1 Plasma fractionation utilizing spray-dried human plasma Pending 01-Oct-2020 000000000
JP-2021183587-A Heterocyclic compounds Pending 22-May-2020 0000000000
JP-2021183586-A Heterocyclic compounds Pending 22-May-2020 0000000000
JP-2021138648-A Oral solid preparation Pending 04-Mar-2020 0000000000
US-20210315198-A1 Compositions and methods of cryopreserving cells Pending 21-Jan-2020 A01N1/0221
To view Takeda Pharmaceutical Company’s complete patent history, request access »

Takeda Pharmaceutical Company Executive Team (53)

Name Title Board Seat Contact Info
Christophe Weber Chief Executive Officer & Board Member
Andrew Plump Ph.D Board Member & President
Giles Platford President
Milano Furuta President
Ramona Sequeira President
You’re viewing 5 of 53 executive team members. Get the full list »

Takeda Pharmaceutical Company Board Members (20)

Name Representing Role Since
000000 00000 00.0 Takeda Pharmaceutical Company Board Member & President 000 0000
0000000000 00000 Takeda Pharmaceutical Company Chief Executive Officer & Board Member 000 0000
00000 00000000 Takeda Pharmaceutical Company Chief Financial Officer, Finance & Board Member 000 0000
00000 0000000 Self Board Member 000 0000
00000 0000 Takeda Pharmaceutical Company Outside Director 000 0000
You’re viewing 5 of 20 board members. Get the full list »

Takeda Pharmaceutical Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takeda Pharmaceutical Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request a free trial

Takeda Pharmaceutical Company Investments & Acquisitions (57)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 28-Jun-2022 000000000 00000 Biotechnology 0000 0000
00000000 0000 10-Jan-2022 0000000000 Drug Discovery 000000000
000000000 000 27-Oct-2021 00000 0000 00000 Biotechnology
0000000000 00 27-Oct-2021 0000000000 Biotechnology 000000000
Maverick Therapeutics 01-Oct-2021 Merger/Acquisition 00000 Drug Discovery 000000000
You’re viewing 5 of 57 investments and acquisitions. Get the full list »

Takeda Pharmaceutical Company Subsidiaries (9)

Company Name Industry Location Founded
Takeda Ventures Corporate Venture Capital San Diego, CA 2001
0000000 Biotechnology Leuven, Belgium 0000
000000 00000000 Drug Discovery Cambridge, MA 0000
000000 (0000000) Distributors/Wholesale Konstanz, Germany 0000
00000 000000000000 Biotechnology Tokyo, Japan 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Takeda Pharmaceutical Company Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 07-Dec-2017 000000000 00000000 00000 Completed
  • 000000 00000000000
00000 05-Apr-2017 00000 00000 00 0000 Completed
  • 000000 00000000000
000 000000 0000000 15-Feb-2017 00000 0000000 Completed
  • 2 buyers
0000000 0000000000 14-Jun-2016 00000 00000 00 000.00 Completed
  • 7 buyers
Seagen 17-Jan-2014 PIPE 000 Completed
You’re viewing 5 of 10 exits. Get the full list »